A CASE REPORT OF MODERN MANAGEMENT OF ACROMEGALY
Abstract:
The management of acromegaly has improved in the last few years, offering new
perspectives, particularly of patients with challenging tumors. We report a case of a male patient with
acromegaly secondary to a growth hormone-secreting pituitary macroadenoma, with transsphenoidal
selective surgical excision of the pituitary mass, followed by tumor recurrence. Since optimal
therapeutic control was not achieved by long-acting somatostatin analog monotherapy after
neurosurgery, the patient was recommended combined treatment with a somatostatin analog and a
dopamine agonist, with incomplete response to therapy, attaining insulin-like growth factor 1 control
only with combined therapy with a long-acting somatostatin analog and a growth hormone receptor
antagonist.
full text article in English (.EN) |